Search Results - "Mashhadi Abolghasem Shirazi, Maryam"

Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope by Mashhadi Abolghasem Shirazi, Maryam, Sadat, Seyed Mehdi, Haghighat, Setareh, Roohvand, Farzin, Arashkia, Arash

“…To relieve the limitations of the human papillomavirus (HPV) vaccines based on L1 capsid protein, vaccine formulations based on RG1 epitope of HPV L2 using…”
Get full text

Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c by Bahramali, Golnaz, Mashhadi Abolghasem Shirazi, Maryam, Hannan, Mina, Aghasadeghi, Mohammad Reza, Khosravy, Mohammad Sadeq, Arjmand, Sina, Sadat, Seyed Mehdi

“…Abstract The coronavirus disease (COVID-19) pandemic has imposed deployment of an effective vaccine as a worldwide health priority. The new variants of…”
Get full text

Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine by Sadat Larijani, Mona, Ramezani, Amitis, Mashhadi Abolghasem Shirazi, Maryam, Bolhassani, Azam, Pouriayevali, Mohammad Hassan, Shahbazi, Sepideh, Sadat, Seyed Mehdi

“…•Lenti virions have been evaluated powerful tools to mature and transduce dendritic cells.•Dendritic cells showed effective antigen carriers which induce both…”
Get full text

Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice by Afchangi, Atefeh, Jalilvand, Somayeh, Arashkia, Arash, Latifi, Tayebeh, Farahmand, Mohammad, Abolghasem Shirazi, Maryam Mashhadi, Mousavi Nasab, Seyed Dawood, Marashi, Sayed Mahdi, Roohvand, Farzin, Shoja, Zabihollah

“…Inconveniences associated with the efficacy and safety of the World Health Organization (WHO) approved/prequalified live attenuated rotavirus (RV) vaccines,…”
Get full text

Co-administration of 2'3'-cGAMP STING activator and CpG-C adjuvants with a mutated form of HPV 16 E7 protein leads to tumor growth inhibition in the mouse model by Dorostkar, Fariba, Arashkia, Arash, Roohvand, Farzin, Shoja, Zabihollah, Navari, Mohsen, Mashhadi Abolghasem Shirazi, Maryam, Shahosseini, Zahra, Farahmand, Mohammad, Shams Nosrati, Mohammad Sadegh, Jalilvand, Somayeh

“…Persistent infection with high-risk genotypes of human papillomavirus (HPV) is the leading cause of cervical cancer. The HPV oncoprotein E7 is constitutively…”
Get full text

Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction by Larijani, Mona Sadat, Mashhadi Abolghasem Shirazi, Maryam, Ramezani, Amitis, Bolhassani, Azam, Pouriayevali, Mohammad Hassan, Sadat, Seyed Mehdi

“…Introduction: Dendritic cells (DCs) play crucial roles in cellular immunity as the most powerful antigen presenting cells. They have been widely used for…”
Get full text

Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations by Shirazi, Maryam Mashhadi Abolghasem, Saedi, Tayebeh Azam, Moghaddam, Zahra Samadi, Nemati, Mahnaz, Shiri, Reza, Negahdari, Babak, Goradel, Nasser Hashemi

“…Oncolytic adenoviruses (OAds), engineered Ads preferentially infect and lyse tumor cells, have attracted remarkable attention as immunotherapy weapons for the…”
Get full text

Heterologous administration of HPV16 E7 epitope-loaded nanocomplexes inhibits tumor growth in mouse model by Goradel, Nasser Hashemi, Negahdari, Babak, Mohajel, Nasir, Malekshahi, Ziba Veisi, Shirazi, Maryam Mashhadi Abolghasem, Arashkia, Arash

“…•Negatively-charged nanoadjuvants act as carrier for positively-modified epitope.•Loading epitope on nanoadjuvants forms epitope-nanoadjuvant…”
Get full text

Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants by Mashhadi Abolghasem Shirazi, Maryam, Arashkia, Arash, Haghighat, Setareh, Roohvand, Farzin, Sadat, Seyed Mehdi

Get full text